清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Effect of vessels that encapsulate tumor clusters (VETC) on the prognosis of different stages of hepatocellular carcinoma after hepatectomy

肝细胞癌 医学 内科学 肝切除术 肿瘤科 外科 切除术
作者
Yanyan Wang,Kun Dong,Kun Wang,Yu Sun,Baocai Xing
出处
期刊:Digestive and Liver Disease [Elsevier]
卷期号:55 (9): 1288-1294 被引量:6
标识
DOI:10.1016/j.dld.2023.03.008
摘要

Background Vessels that encapsulate tumor clusters (VETC) is a newly discovered vascular pattern in hepatocellular carcinoma (HCC), representing high biological aggressiveness. However, it remains unclear whether the prognostic impact of VETC differs in patients with different staged HCC. This study aimed to evaluate the effect of VETC on the prognosis of patients with HCC at different stages after hepatectomy. Methods Patients who underwent hepatectomy for HCC between January 2005 and December 2019 were assessed, and stratified according to their Barcelona Clinic Liver Cancer (BCLC) stage. Overall survival (OS) and disease-free survival (DFS) were compared between patients with and without VETC. Independent risk factors of OS and DFS were determined by multivariable Cox regression analyses. Results A total of 837 consecutive patients undergoing curative hepatectomy were enrolled, and VETC pattern was found in 339 (40.5%) patients. The incidence of VETC in patients at BCLC-0, BCLC-A, BCLC-B and BCLC-C stage was 17.8%, 40.2%, 53.7% and 66.0%, respectively. In the entire patients, VETC+ patients had significantly lower OS and DFS than VETC- patients. After stratification of patients according to BCLC stage, VETC was associated with worse OS and DFS only in patients at BCLC-A and BCLC-B stages, but not in those at BCLC-0 and BCLC-C stages. Multivariable analyses also revealed that VETC was an independent risk factor for OS and DFS in both the patients at BCLC-A and BCLC-B stages. Conclusions VETC is associated with poor OS and DFS in patients with HCC at BCLC-A and BCLC-B stage after hepatectomy, but it does not affect the survival of patients with HCC at BCLC-0 and BCLC-C stage after hepatectomy.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ceeray23应助科研通管家采纳,获得10
19秒前
顾矜应助科研通管家采纳,获得10
19秒前
KsL2177完成签到 ,获得积分10
26秒前
GingerF应助fxtx1234采纳,获得50
1分钟前
Xiaoqiang完成签到,获得积分10
1分钟前
rose完成签到,获得积分10
1分钟前
英俊的铭应助Xiaoqiang采纳,获得10
2分钟前
2分钟前
胖虎虎发布了新的文献求助10
2分钟前
Akim应助科研通管家采纳,获得10
2分钟前
ceeray23应助科研通管家采纳,获得10
2分钟前
acat完成签到 ,获得积分10
2分钟前
chenzhuod完成签到,获得积分10
2分钟前
2分钟前
上官若男应助胖虎虎采纳,获得10
3分钟前
一颗红葡萄完成签到 ,获得积分0
3分钟前
呃呃发布了新的文献求助10
3分钟前
4分钟前
ceeray23应助科研通管家采纳,获得10
4分钟前
4分钟前
4分钟前
沉沉完成签到 ,获得积分0
5分钟前
5分钟前
5分钟前
mlv应助科研通管家采纳,获得10
6分钟前
ceeray23应助科研通管家采纳,获得10
6分钟前
ceeray23应助科研通管家采纳,获得10
6分钟前
6分钟前
6分钟前
胖虎虎发布了新的文献求助10
6分钟前
Sandstorm发布了新的文献求助10
6分钟前
ktw完成签到,获得积分10
6分钟前
7分钟前
277完成签到 ,获得积分10
7分钟前
慕青应助胖虎虎采纳,获得10
7分钟前
智慧金刚完成签到 ,获得积分10
7分钟前
7分钟前
Sandstorm完成签到,获得积分10
8分钟前
meeteryu完成签到,获得积分10
8分钟前
8分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Handbook of pharmaceutical excipients, Ninth edition 5000
Aerospace Standards Index - 2026 ASIN2026 3000
Polymorphism and polytypism in crystals 1000
Signals, Systems, and Signal Processing 610
Discrete-Time Signals and Systems 610
T/SNFSOC 0002—2025 独居石精矿碱法冶炼工艺技术标准 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6042677
求助须知:如何正确求助?哪些是违规求助? 7796645
关于积分的说明 16237358
捐赠科研通 5188399
什么是DOI,文献DOI怎么找? 2776436
邀请新用户注册赠送积分活动 1759524
关于科研通互助平台的介绍 1643028